Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsPERFUSION, BILIARYGeneric

MOCTANIN

MONOCTANOIN

Standard Dose
100%
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview MOCTANIN is listed in Drugs@FDA under application 019368 (NDA).

Marketing status: Discontinued Active ingredient MONOCTANOIN Form and strength LIQUID;PERFUSION, BILIARY - 100% Sponsor ETHITEK Submission history Latest submission status date: 2002-11-12 00:00:00.

Structured Monograph

Clinical summary

Approval overview MOCTANIN is listed in Drugs@FDA under application 019368 (NDA). Marketing status: Discontinued Active ingredient MONOCTANOIN Form and strength LIQUID;PERFUSION, BILIARY - 100% Sponsor ETHITEK Submission history Latest submission status date: 2002-11-12 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.
MOCTANIN (MONOCTANOIN) | Drug Monograph | MedicHelpline